Display Settings:

Format

Send to:

Choose Destination
    Osteoporos Int. 2011 Mar;22(3):1003-6. Epub 2010 May 11.

    Severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica.

    Source

    Orthopedic and Traumatology Unit, Department of Clinical Methodology and Surgical Techniques, University of Bari, Bari, Italy.

    Abstract

    In this work, we describe the clinical and instrumental results of our experience, the first reported in the literature, of the administration of teriparatide to treat severe osteoporosis secondary to epidermolysis bullosa. Already after 2 months of therapy, the patient, a 20-year-old affected by a recessive form of epidermolysis bullosa dystrophica, had less pain and a functional recovery resulting in an improved autonomy; a satisfactory increase in the densitometric values was documented.

    PMID:
    20458569
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Springer

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk